WHO ICTRP trial
COMPARE
JPRN-jRCTs052200095 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs052200095 |
|---|---|
| Public title | COMPARE |
| Scientific title | Conventional TACE using menbrane pumping device on hepatocellular carcinoma treatment |
| Primary sponsor | Tanaka Toshihiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | hepatocellular carcinoma |
| Interventions | Injection of lipiodol / epirubicin emulsion formed by using the devise |
| Registration date | Dec 15, 2020 |
| Target size | 50 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: